Distinct domains of the mu-opioid receptor control uncoupling and internalization.
D000409:Alanine / Q000235:genetics; D019943:Amino Acid Substitution; D000818:Animals; D019393:Arrestin / Q000378:metabolism; D002478:Cells, Cultured; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels; D054770:G-Protein-Coupled Receptor Kinase 3; D049452:Green Fluorescent Proteins; D006801:Humans; D008164:Luminescent Proteins / Q000378:metabolism; D009020:Morphine / Q000494:pharmacology; D009865:Oocytes; D010587:Phagocytosis / Q000187:drug effects; D010766:Phosphorylation; D015221:Potassium Channels / Q000378:metabolism; D024661:Potassium Channels, Inwardly Rectifying; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D017434:Protein Structure, Tertiary; D017450:Receptors, Opioid, mu / Q000737:chemistry / Q000378:metabolism*; D013912:Threonine / Q000235:genetics; D014982:Xenopus laevis
D019393:Arrestin; D051676:G Protein-Coupled Inwardly-Rectifying Potassium Channels; D008164:Luminescent Proteins; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D017450:Receptors, Opioid, mu; D049452:Green Fluorescent Proteins; D013912:Threonine; D009020:Morphine; D017346:Protein Serine-Threonine Kinases; D054770:G-Protein-Coupled Receptor Kinase 3; C517848:GRK3 protein, human; D000409:Alanine